Document Detail


Italian Diffuse/Multivessel Disease ABSORB Prospective Registry under the auspices of Società Italiana di Cardiologia Invasive-GISE (IT-DISAPPEARS): study design and rationale.
MedLine Citation:
PMID:  25469734     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
BACKGROUND: The Absorb Bioresorbable Vascular Scaffold System (Absorb BVS) is an everolimus-eluting bioresorbable vascular scaffold able to provide temporary scaffolding and antiproliferative drug delivery for the treatment of coronary artery disease. This temporary scaffolding could be the true feature to overcome the limitations of the conventional metallic stents. A growing body of evidence worldwide is supporting its implementation into daily practice as being associated with comparable results as the second-generation everolimus-eluting stent. However, these pieces of evidence come from 'studies in which the majority of the patients had low-risk stenoses', whereas patients with more complex coronary artery disease could benefit the most from the Absorb BVS technology.
METHODS: The aim of the IT-DISAPPEARS is to investigate the procedural and clinical performance of the Absorb BVS in patients with long (>24 mm), single-vessel coronary disease or with multivessel disease. At least 50 centers across the Italian territory will enroll 1000 patients with either stable or acute coronary syndromes. Follow-up will end up at 5 years. Primary endpoint will be the cumulative hierarchical incidence of major adverse cardiac events at 1 year, defined as: cardiac death, nonfatal target vessel myocardial infarction, or clinically driven target lesion revascularization. The efficacy as well as safety parameters will be evaluated along with a detailed evaluation of the dual antiplatelet therapy duration/interruption.
CONCLUSION: The IT-DISAPPEARS could provide the first evidence worldwide concerning the performance of Absorb BVS in patients with high-risk diffuse coronary disease.
Authors:
Testa Luca; Biondi Zoccai Giuseppe; Tomai Fabrizio; Ribichini Flavio; Indolfi Ciro; Tamburino Corrado; Bartorelli Antonio; Petronio Anna Sonia; Bedogni Francesco; De Carlo Marco
Related Documents :
19169014 - Role of vasopressin and vasopressin receptor antagonists in type i cardiorenal syndrome.
2178374 - Cardiac glycosides and congestive heart failure.
18163014 - Aminothiol redox alterations in patients with chronic heart failure of ischaemic or non...
24105294 - Splenic infarction after n-butyl-2-cyanoacrylate injection for gastric varices: why doe...
7568904 - Role of nitric oxide in the regulation of myocardial function.
17437574 - Reverse electrical remodeling of the atria post cardioversion in patients who remain in...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-12-2
Journal Detail:
Title:  Journal of cardiovascular medicine (Hagerstown, Md.)     Volume:  -     ISSN:  1558-2035     ISO Abbreviation:  J Cardiovasc Med (Hagerstown)     Publication Date:  2014 Dec 
Date Detail:
Created Date:  2014-12-3     Completed Date:  -     Revised Date:  2014-12-4    
Medline Journal Info:
Nlm Unique ID:  101259752     Medline TA:  J Cardiovasc Med (Hagerstown)     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Stress echocardiography pattern: a promising noninvasive test for detection of myocardial bridging w...
Next Document:  The controversial relationship between exercise and atrial fibrillation: clinical studies and pathop...